Scores are 0 to 100 against every US stock we track; 50 is average. Recomputed after every US market close.
Fiscal year to December 2025, from the company's annual filing with the SEC.
| Salesyearly sales | $59.1B |
| Sales growthchange from the year before | +3.5% |
| Operating marginshare of sales left after running the business | 8.0% |
| Net marginshare of sales kept as profit | 5.7% |
| Return on invested capitalprofit made on each $100 put into the business | 10.2% |
| Return on equityprofit vs. shareholders' accounting value | 21.9% |
| Debt / equitydebt vs. shareholders' accounting value | 1.39 |
| Change in share countnegative = the company is buying back its shares | -1.4% |
5 insiders sold $27.0M (5% under pre-arranged plans) on the open market.
| Nocella Andrew PEVP & Chief Commercial Officer | SoldAug 4 | 3,000 shat $132.30 · $397K |
| Leskinen Michael D.EVP & Chief Financial Officer | Sold (plan)Aug 3 | 10,000 shat $128.19 · $1.3M |
| Hart Brett JPresident | SoldJul 28 | 30,108 shat $120.72 · $3.6M |
From Form 4 filings with the SEC. Open-market trades only. "Plan" = a sale set up in advance under a 10b5-1 plan, usually routine.
Not financial advice. Research and education only: the same view for everyone, with no regard to your circumstances. Past results do not predict future ones. Decide for yourself or with a licensed adviser. Terms · Privacy